MCOA (Marijuana Company of America) Research & Development: $0.00 Mil (TTM As of Sep. 2022)


What is Marijuana Company of America Research & Development?

Marijuana Company of America MCOA -99.00% Research & Development is $0.00 Mil as of Sep. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. Marijuana Company of America's Research & Development for the three months ended in Sep. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $0.00 Mil.

Marijuana Company of America  (OTCPK:MCOA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Marijuana Company of America Research & Development Related Terms

Marijuana Company of America Research & Development Historical Data

* Premium members only.

The historical data trend for Marijuana Company of America's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marijuana Company of America Research & Development Chart

Marijuana Company of America Annual Data
Trend Dec00 Dec01 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Marijuana Company of America Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Marijuana Company of America Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Marijuana Company of America (MCOA) has a Research & Development of $0.00 Mil as of Sep. 2022. Research and development expense is the total cost for research and development activities. View historical data on Marijuana Company of America and its competitors.
Is Marijuana Company of America's Research & Development too high?
Marijuana Company of America's current Research & Development is $0.00 Mil.
How does Marijuana Company of America's Research & Development compare to CPHI and BSPK?
Marijuana Company of America's Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Marijuana Company of America and its competitors. Marijuana Company of America's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marijuana Company of America stock overvalued right now?
Marijuana Company of America (MCOA) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Marijuana Company of America (MCOA), the current Research & Development is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marijuana Company of America Business Description

Address 633 West 5th Street, Suite 2826, Los Angeles, CA, USA, 90071
Marijuana Company of America Inc is an owner and operator of licensed cannabis cultivation, processing and dispensary facilities and a developer, producer and distributor of branded cannabis and cannabidiol (CBD) products in the United States.